Does elevated DHT with low testosterone suggest increased downstream androgen conversion?

DHT is an active androgen metabolite, and its relation to testosterone is biologically well established. In a 52-year-old man, a high DHT result alongside low total and free testosterone can suggest relatively greater downstream androgen metabolism, but it is not a diagnostic measure of increased 5α-reductase activity.

Established biology and mechanisms

• 5α-reductase directly and irreversibly converts testosterone to DHT using NADPH. The main isoenzymes are SRD5A1 and SRD5A2.
• SRD5A2, with high affinity for testosterone, is prominent in prostate, genital skin, epididymis, seminal vesicles, and fetal genital tissue. SRD5A1 is more broadly expressed in liver, skin, scalp/hair follicles, and brain.
• DHT is a potent androgen-receptor agonist. Serum levels, however, may not represent tissue androgen exposure because DHT can be synthesized, metabolized, and act locally within tissues.
• DHT can also arise through a testosterone-independent route from androstenedione via androstanedione, including in adipose tissue.

Interpreting a high DHT-to-testosterone pattern

• About 70% of circulating DHT is generated by peripheral conversion, so disproportionately high DHT relative to testosterone is mechanistically compatible with greater 5α-reductase-mediated conversion.
• This pattern does not establish amplified conversion: neither serum DHT nor the DHT:testosterone ratio has a validated cutoff for this purpose. Age, testosterone substrate availability, tissue metabolism, medication exposure, and sampling factors can alter the ratio.
• Analytical method matters substantially. Direct DHT immunoassays may overestimate DHT through steroid cross-reactivity; LC–MS/MS is preferred.

Clinical implications

• “Below-optimal” testosterone should mean symptoms/signs plus consistently and unequivocally low results, confirmed with repeat morning fasting total testosterone testing. When needed, free testosterone should be measured by equilibrium dialysis or calculated from total testosterone, SHBG, and albumin.

Bottom line

• The conversion biology is established; a high DHT despite low testosterone makes increased peripheral conversion a reasonable hypothesis, but reliable repeat LC–MS/MS-based testing and clinical context are required before attributing the finding to heightened 5α-reductase activity.